8-K Announcements
6Apr 29, 2026·SEC
Apr 16, 2026·SEC
Mar 19, 2026·SEC
The Allstate Corporation (ALL) fundamental analysis — strengths, weaknesses & financial health based on data analysis
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when ALL posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
The Allstate Corporation (ALL) stock price & volume — 10-year historical chart
The Allstate Corporation (ALL) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
The Allstate Corporation (ALL) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 29, 2026 | $10.65vs $7.31+45.7% | $14.6Bvs $15.1B-2.9% |
| Q1 2026 | Feb 4, 2026 | $14.31vs $9.83+45.6% | $14.6Bvs $14.5B+0.3% |
| Q4 2025 | Nov 5, 2025 | $11.17vs $7.67+45.6% | $17.1Bvs $15.7B+8.8% |
| Q3 2025 | Jul 30, 2025 | $5.94vs $3.25+82.8% | $16.6Bvs $15.2B+9.3% |
The Allstate Corporation (ALL) competitors in Personal auto and homeowners insurers — business model, growth, and fundamentals comparison
The Allstate Corporation (ALL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
The Allstate Corporation (ALL) annual income statement — 10-year revenue, gross profit & net income history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 39.41B | 39.81B | 41.1B | 41.69B | 48.68B | 50.62B | 56.59B | 63.52B | 66.46B | 67.14B |
Revenue Growth % | 5.37% | 1.04% | 3.24% | 1.43% | 16.76% | 3.98% | 11.8% | 12.24% | 4.64% | 3.73% |
Medical Costs & Claims | 29.24B | 30.63B | 29.96B | 28.66B | 36.65B | 44.94B | 49.42B | 49.02B | 44.37B | 40.4B |
Medical Cost Ratio % | 74.21% | 76.92% | 72.9% | 68.75% | 75.28% | 88.78% | 87.33% | 77.17% | 66.77% | 60.17% |
Gross Profit | 10.16B▲ 0% | 9.19B▼ 9.6% | 11.14B▲ 21.2% | 13.03B▲ 16.9% | 12.03B▼ 7.6% | 5.68B▼ 52.8% | 7.17B▲ 26.3% | 14.5B▲ 102.2% | 22.09B▲ 52.3% | 26.74B▲ 0% |
Gross Margin % | 25.79% | 23.08% | 27.1% | 31.25% | 24.72% | 11.22% | 12.67% | 22.83% | 33.23% | 39.83% |
Gross Profit Growth % | 26.33% | -9.59% | 21.25% | 16.94% | -7.64% | -52.82% | 26.33% | 102.18% | 52.32% | - |
Operating Expenses | 5.61B | 6.56B | 5.7B | 6.22B | 5.57B | 7.51B | 7.52B | 8.74B | 8.93B | 11.1B |
OpEx / Revenue % | 14.25% | 16.48% | 13.86% | 14.93% | 11.43% | 14.83% | 13.29% | 13.76% | 13.44% | 16.53% |
Depreciation & Amortization | 483M | 511M | 647M | 686M | 1.09B | 847M | 704M | 555M | 482M | 397M |
Combined Ratio % | 88.46% | 93.4% | 86.76% | 83.69% | 86.72% | 103.62% | 100.61% | 90.93% | 80.2% | 76.7% |
Operating Income | 4.55B▲ 0% | 2.63B▼ 42.2% | 5.44B▲ 107.1% | 6.8B▲ 25.0% | 6.47B▼ 4.9% | -1.83B▼ 128.3% | -348M▲ 81.0% | 5.76B▲ 1755.5% | 13.16B▲ 128.4% | 15.64B▲ 0% |
Operating Margin % | 11.54% | 6.6% | 13.24% | 16.31% | 13.28% | -3.62% | -0.61% | 9.07% | 19.8% | 23.3% |
Operating Income Growth % | 65.18% | -42.23% | 107.12% | 24.97% | -4.94% | -128.3% | 80.98% | 1755.46% | 128.36% | - |
EBITDA | 5.03B | 3.14B | 6.09B | 7.49B | 7.55B | -983M | 356M | 6.32B | 13.64B | 16.04B |
EBITDA Margin % | 12.77% | 7.88% | 14.82% | 17.96% | 15.51% | -1.94% | 0.63% | 9.94% | 20.52% | 23.89% |
Interest Expense | 335M | 332M | 327M | 318M | 330M | 335M | 379M | 400M | 399M | 397M |
Non-Operating Income | -335M | -332M | -327M | -318M | -330M | -335M | -379M | -400M | -399M | -326M |
Pretax Income | 4.55B▲ 0% | 2.63B▼ 42.2% | 5.44B▲ 107.1% | 6.8B▲ 25.0% | 6.47B▼ 4.9% | -1.83B▼ 128.3% | -348M▲ 81.0% | 5.76B▲ 1755.5% | 13.16B▲ 128.4% | 15.54B▲ 0% |
Pretax Margin % | 11.54% | 6.6% | 13.24% | 16.31% | 13.28% | -3.62% | -0.61% | 9.07% | 19.8% | 23.15% |
Income Tax | 995M | 468M | 1.12B | 1.37B | 1.29B | -488M | -135M | 1.16B | 2.89B | 3.42B |
Effective Tax Rate % | 21.87% | 17.81% | 20.5% | 20.19% | 19.98% | 26.67% | 38.79% | 20.17% | 21.97% | 21.98% |
Net Income | 3.55B▲ 0% | 2.16B▼ 39.2% | 4.85B▲ 124.4% | 5.58B▲ 15.0% | 1.61B▼ 71.1% | -1.29B▼ 179.9% | -188M▲ 85.4% | 4.67B▲ 2582.4% | 10.28B▲ 120.3% | 12.14B▲ 0% |
Net Margin % | 9.02% | 5.43% | 11.79% | 13.37% | 3.32% | -2.55% | -0.33% | 7.35% | 15.47% | 18.09% |
Net Income Growth % | 89.34% | -39.22% | 124.4% | 15.04% | -71.05% | -179.86% | 85.42% | 2582.45% | 120.31% | 200.32% |
EPS (Diluted) | 9.35▲ 0% | 6.12▼ 34.5% | 14.03▲ 129.2% | 17.31▲ 23.4% | 17.25▼ 0.3% | -5.03▼ 129.2% | -1.20▲ 76.1% | 16.99▲ 1515.8% | 38.19▲ 124.8% | 46.25▲ 0% |
EPS Growth % | 100.21% | -34.55% | 129.25% | 23.38% | -0.35% | -129.16% | 76.14% | 1515.83% | 124.78% | 209.56% |
EPS (Basic) | 9.50 | 6.21 | 14.25 | 17.53 | 17.50 | -5.03 | -1.20 | 17.22 | 38.68 | - |
Diluted Shares Outstanding | 367.8M | 353.2M | 333.5M | 315.5M | 299.1M | 271.2M | 262.5M | 267.8M | 264.7M | 262.6M |
The Allstate Corporation (ALL) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Assets | 112.42B | 112.25B | 119.95B | 125.99B | 99.44B | 97.99B | 103.36B | 111.62B | 119.76B | 123.97B |
Asset Growth % | 3.51% | -0.15% | 6.86% | 5.03% | -21.07% | -1.46% | 5.48% | 7.99% | 7.29% | 27.74% |
Total Investment Assets | 6.74B | 7.5B | 8.08B | 4.56B | 8.02B | 8.11B | 8.38B | 9.26B | 83.24B | 4M |
Long-Term Investments | 4.8B | 4.48B | 3.82B | -2.24B | 4.01B | 3.94B | 3.24B | 4.72B | 78.35B | 300.19B |
Short-Term Investments | 1.94B | 3.03B | 4.26B | 6.81B | 4.01B | 4.17B | 5.14B | 4.54B | 4.89B | 4.71B |
Total Current Assets | 17.27B | 19.25B | 20.28B | 20.8B | 23.16B | 23.69B | 24.72B | 24.78B | 26.25B | 32.2B |
Cash & Equivalents | 617M | 499M | 338M | 311M | 763M | 736M | 722M | 704M | 678M | 697M |
Receivables | 14.71B | 15.72B | 15.68B | 13.68B | 18.39B | 18.78B | 18.85B | 19.54B | 20.68B | 75.76B |
Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.08B |
Goodwill & Intangibles | 2.74B | 3.24B | 3.03B | 2.82B | 4.92B | 4.68B | 4.47B | 4B | 9.84B | 31.22B |
Goodwill | 2.18B | 2.53B | 2.54B | 2.37B | 3.5B | 3.5B | 3.5B | 3.25B | 3.12B | 3.12B |
Intangible Assets | 556M | 713M | 481M | 453M | 1.42B | 1.18B | 966M | 754M | 6.72B | 0 |
PP&E (Net) | 1.07B | 1.04B | 1.15B | 1.06B | 939M | 987M | 859M | 669M | 627M | 606M |
Other Assets | 86.55B | 84.24B | 91.68B | 103.56B | 66.41B | 64.31B | 69.86B | 77.22B | 4.69B | 7.58B |
Total Liabilities | 89.87B | 90.94B | 93.95B | 95.77B | 74.31B | 80.63B | 85.73B | 90.25B | 89.17B | 92.39B |
Total Debt | 6.35B | 6.45B | 6.63B | 7.83B | 7.98B | 7.96B | 7.94B | 8.09B | 7.49B | 7.49B |
Net Debt | 5.73B | 5.95B | 6.29B | 7.51B | 7.21B | 7.23B | 7.22B | 7.38B | 6.81B | 6.79B |
Long-Term Debt | 6.35B | 6.45B | 6.63B | 7.83B | 7.98B | 7.96B | 7.94B | 8.09B | 6.94B | 7.49B |
Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 550M | 0 |
Total Current Liabilities | 13.11B | 14.89B | 16.06B | 0 | 0 | 0 | 0 | 0 | 70.94B | 84.89B |
Accounts Payable | 6.47B | 7.16B | 6.91B | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29.08B | 28.86B |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41.31B | 42.79B |
Deferred Taxes | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 0 | 0 | 1000K | 538M |
Other Liabilities | 69.63B | 69.17B | 70.11B | 87.56B | 65.5B | 72.66B | 77.79B | 82.17B | 11.07B | 0 |
Total Equity | 22.55B▲ 0% | 21.31B▼ 5.5% | 26B▲ 22.0% | 30.22B▲ 16.2% | 25.13B▼ 16.8% | 17.36B▼ 30.9% | 17.63B▲ 1.5% | 21.37B▲ 21.2% | 30.59B▲ 43.2% | 31.59B▲ 0% |
Equity Growth % | 9.61% | -5.49% | 21.99% | 16.23% | -16.84% | -30.9% | 1.54% | 21.2% | 43.16% | 147.56% |
Shareholders Equity | 22.55B | 21.31B | 26B | 30.22B | 25.18B | 17.49B | 17.77B | 21.44B | 30.61B | 31.61B |
Minority Interest | 0 | 0 | 0 | 0 | -52M | -125M | -140M | -75M | -21M | -20M |
Retained Earnings | 43.16B | 44.03B | 48.07B | 52.77B | 53.29B | 50.97B | 49.72B | 53.29B | 62.39B | 64.54B |
Common Stock | 9M | 9M | 9M | 9M | 9M | 9M | 9M | 9M | 9M | 9M |
Accumulated OCI | 303M | 115M | 1.95B | 3.3B | 655M | -2.39B | -700M | -889M | 255M | -292M |
Return on Equity (ROE) | 16.48% | 9.85% | 20.49% | 19.84% | 5.83% | -6.07% | -1.07% | 23.94% | 39.58% | 42.74% |
Return on Assets (ROA) | 3.22% | 1.92% | 4.17% | 4.53% | 1.43% | -1.31% | -0.19% | 4.34% | 8.89% | 10.12% |
Equity / Assets | 20.06% | 18.99% | 21.67% | 23.98% | 25.27% | 17.72% | 17.06% | 19.14% | 25.54% | 25.48% |
Debt / Equity | 0.28x | 0.30x | 0.26x | 0.26x | 0.32x | 0.46x | 0.45x | 0.38x | 0.24x | 0.24x |
Book Value per Share | 61.31 | 60.34 | 77.96 | 95.77 | 84.01 | 64.02 | 67.16 | 79.79 | 115.56 | 120.29 |
Tangible BV per Share | 53.87 | 51.16 | 68.88 | 86.83 | 67.55 | 46.77 | 50.14 | 64.85 | 78.39 | 108.41 |
The Allstate Corporation (ALL) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 4.31B | 5.17B | 5.13B | 5.49B | 5.12B | 5.12B | 4.23B | 8.93B | 10.11B | 11.71B |
Operating CF Growth % | 8.04% | 19.96% | -0.89% | 7.06% | -6.83% | 0.1% | -17.44% | 111.23% | 13.2% | 138.66% |
Operating CF / Revenue % | 10.95% | 13% | 12.48% | 13.17% | 10.51% | 10.12% | 7.47% | 14.06% | 15.21% | 17.44% |
Net Income | 3.19B | 2.16B | 4.85B | 5.58B | 1.57B | -1.36B | -213M | 4.6B | 10.28B | 12.14B |
Depreciation & Amortization | 483M | 511M | 647M | 686M | 1.09B | 847M | 704M | 555M | 482M | 957M |
Stock-Based Compensation | 0 | 138M | 120M | 137M | 129M | 102M | 0 | 0 | 0 | 0 |
Deferred Taxes | 0 | 0 | -120M | -137M | -129M | -102M | 0 | 0 | 0 | 0 |
Other Non-Cash Items | 350M | 1.85B | -1.03B | -773M | 2.55B | 5.69B | 309M | 188M | -1.49B | -2.53B |
Working Capital Changes | 292M | 511M | 666M | 2M | -88M | -53M | 3.43B | 3.59B | 832M | 2.76B |
Cash from Investing | -1.21B | -1.72B | -2.81B | -3.44B | 510M | -1.73B | -3B | -8.25B | -7.25B | -8.59B |
Capital Expenditures | -299M | -277M | -433M | -308M | -345M | -420M | -267M | -210M | -228M | -253M |
Acquisitions | -1.67B | -1.47B | -594M | 86M | -2.42B | -288M | -180M | 5M | 3.04B | 0 |
Purchase of Investments | -38.76B | -44.36B | -39.88B | -47.01B | -41.91B | -46.51B | -33.27B | 0 | -92.29B | 601M |
Sale/Maturity of Investments | 39.56B | 44.53B | 38.25B | 43.14B | 44.54B | 45.22B | 30.76B | 0 | 82.22B | 15.14B |
Other Investing | -46M | -135M | -149M | 653M | 639M | 268M | -37M | -8.05B | 0 | -24.07B |
Cash from Financing | -2.92B | -3.57B | -2.48B | -2.01B | -5.24B | -3.42B | -1.24B | -697M | -2.88B | -3.46B |
Dividends Paid | -641M | -748M | -787M | -776M | -999M | -1.03B | -1.03B | -1.08B | -1.15B | -1.17B |
Share Repurchases | -1.5B | -2.69B | -2.87B | -2.02B | -3.57B | -2.52B | -335M | -2M | -1.23B | -1.75B |
Stock Issued | 0 | 557M | 1.53B | 63M | 114M | 0 | 0 | 0 | 48M | 13M |
Debt Issuance (Net) | 0 | 1000K | 1000K | 1000K | -1000K | 0 | -1000K | 1000K | -1000K | -1000K |
Other Financing | -787M | -793M | -537M | -462M | -349M | 131M | 119M | 239M | 57M | 42M |
Net Change in Cash | 181M▲ 0% | -118M▼ 165.2% | -161M▼ 36.4% | 39M▲ 124.2% | 452M▲ 1059.0% | -27M▼ 106.0% | -14M▲ 48.1% | -18M▼ 28.6% | -26M▼ 44.4% | -143M▲ 0% |
Exchange Rate Effect | 0 | 0 | 0 | 0 | 66M | 0 | 0 | 0 | 0 | 201M |
Cash at Beginning | 436M | 617M | 499M | 338M | 311M | 763M | 736M | 722M | 704M | 678M |
Cash at End | 617M | 499M | 338M | 377M | 763M | 736M | 722M | 704M | 678M | 697M |
Free Cash Flow | 4.01B▲ 0% | 4.9B▲ 22.0% | 4.7B▼ 4.1% | 5.18B▲ 10.4% | 4.77B▼ 7.9% | 4.7B▼ 1.5% | 3.96B▼ 15.7% | 8.72B▲ 120.2% | 9.88B▲ 13.3% | 11.53B▲ 0% |
FCF Growth % | 9.1% | 21.99% | -4.12% | 10.37% | -7.95% | -1.47% | -15.74% | 120.17% | 13.31% | 28.59% |
FCF Margin % | 10.19% | 12.3% | 11.42% | 12.43% | 9.8% | 9.29% | 7% | 13.73% | 14.87% | 17.18% |
FCF per Share | 10.92 | 13.87 | 14.08 | 16.43 | 15.95 | 17.33 | 15.09 | 32.57 | 37.33 | 43.91 |
The Allstate Corporation (ALL) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Combined Ratio | 88.46% | 93.4% | 86.76% | 83.69% | 86.72% | 103.62% | 100.61% | 90.93% | 80.2% | 76.7% |
Medical Cost Ratio | 74.21% | 76.92% | 72.9% | 68.75% | 75.28% | 88.78% | 87.33% | 77.17% | 66.77% | 60.17% |
Return on Equity (ROE) | 16.48% | 9.85% | 20.49% | 19.84% | 5.83% | -6.07% | -1.07% | 23.94% | 39.58% | 42.74% |
Return on Assets (ROA) | 3.22% | 1.92% | 4.17% | 4.53% | 1.43% | -1.31% | -0.19% | 4.34% | 8.89% | 10.12% |
Equity / Assets | 20.06% | 18.99% | 21.67% | 23.98% | 25.27% | 17.72% | 17.06% | 19.14% | 25.54% | 25.48% |
Book Value / Share | 61.31 | 60.34 | 77.96 | 95.77 | 84.01 | 64.02 | 67.16 | 79.79 | 115.56 | 120.29 |
Debt / Equity | 0.28x | 0.30x | 0.26x | 0.26x | 0.32x | 0.46x | 0.45x | 0.38x | 0.24x | 0.24x |
Revenue Growth | 5.37% | 1.04% | 3.24% | 1.43% | 16.76% | 3.98% | 11.8% | 12.24% | 4.64% | 3.73% |
The Allstate Corporation (ALL) SEC filings — annual & quarterly reports (10-K, 10-Q)
Apr 29, 2026·SEC
Apr 16, 2026·SEC
Mar 19, 2026·SEC
The Allstate Corporation (ALL) stock FAQ — growth, dividends, profitability & financials explained
The Allstate Corporation (ALL) grew revenue by 4.6% over the past year. Growth has been modest.
Yes, The Allstate Corporation (ALL) is profitable, generating $12.14B in net income for fiscal year 2025 (15.5% net margin).
Yes, The Allstate Corporation (ALL) pays a dividend with a yield of 1.77%. This makes it attractive for income-focused investors.
The Allstate Corporation (ALL) has a return on equity (ROE) of 39.6%. This is excellent, indicating efficient use of shareholder capital.
The Allstate Corporation (ALL) has a combined ratio of 80.2%. A ratio below 100% indicates underwriting profitability.